Multiple Sclerosis Management 2013: A Changing Landscape


Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Multiple Sclerosis Management 2013: A Changing Landscape

  1. 1. Confidential. Remedica Medical Education and Publishing. © 2013 REMEDICAMultiple Sclerosis Management 2013:A Changing Landscape26–27 April 2013, Vienna
  2. 2. Confidential. Remedica Medical Education and Publishing. © 2013 REMEDICAMEETING INFORMATIONMeeting ChairProfessor Per Soelberg-Sørensen, København, DenmarkSteering CommitteeProfessor Wolfgang Brück, Göttingen, GermanyProfessor Giancarlo Comi, Milan, ItalyProfessor Massimo Filippi, Milan, ItalyFacultyApproximately 20 – 25 high-profile key opinion leaders from across the world; the names listed havein the programme below have confirmed acceptance of the invitation to participateAudienceFor an audience of up to 400 European neurologistsMeeting aimTo explore the significant advances in multiple sclerosis management over the past two decades,modern-day perspectives and challenges, and new and emerging treatment options and theirtranslation into clinical practiceMeeting styleSessions will include: plenary presentations smaller breakout sessions and workshops a formal debateContinuing medical educationAccreditation will be sought via EACCME and EACICSupportAn independent educational meeting funded by an educational grant from Teva Pharmaceuticals
  3. 3. Confidential. Remedica Medical Education and Publishing. © 2013 REMEDICAProgrammeFriday 26thApril 2013Time Session Faculty13:00 Welcome and introduction P Soelberg Sørensen13:05 Keynote lectureMultiple sclerosis management 2013: Where are we? F LublinSession 1: 20 Years of Progress in Multiple Sclerosis Per Soelberg Sørensen &Massimo Filippi13:45 Benefit–risk of injectable MS therapies F Fazekas14:15 Second-line options for MS following first-line treatment failure B Kieseier14:45 Panel discussion15:15 Break15:35 Workshop session 1Symptomatic treatmentOptions for the treatment of spasticity in MS M ZaffaroniManagement of tremor in MS J Benito-LeónSleep disorders and fatigue in MS L StroberManagement of special populationsTreating MS during pregnancy M HoutchensManagement of MS in paediatric patients M TardieuTreatment issuesClinical experience with the new oral agents G ComiHaematopoietic stem cell therapy for MS GL MancardiManagement of optic neuritis attacks in MS R KapoorPathologyPathology–imaging correlations in MS H LassmannCortical demyelination and correlation with cognitive declinein MSM Khalil16:35 Workshop session 2 (repeat of Workshop session 1 topics)17:35 Guest lectureUnderstanding and communicating risks and benefits in chronicdiseasesA Fagerlin18:15 End of day 1
  4. 4. Confidential. Remedica Medical Education and Publishing. © 2013 REMEDICASaturday 27thApril 201309:00 Wake-up lectureEmerging insights into disease pathophysiology from studiesof PPMS, SPMS and PRMSH LassmannSession 2: Insights and Challenges for Modern Multiple SclerosisManagementGiancarlo Comi &Wolfgang Brück09:40 Assessing disease progression:Physician and patient perspectivesA Thompson10:10 Advanced MRI techniques M Filippi10:40 Panel discussion11:10 Break11:30 Workshop session 3 (repeat of Workshop session 1 topics)12:30 LunchSession 3: The Advent of Oral Multiple Sclerosis Agents Wolfgang Brück &Massimo Filippi13:30 Mechanism of action of oral agents for MS W Brück14:00 Recent clinical investigations with new oral agentsfor MSG Comi14:30 Prospects for individualised therapy for MS G Giovannoni15:00 Panel discussion15:20 DebateWith the introduction of oral agents, injectables will have noplace in the modern management of MSFor: O FernándezAgainst: P Soelberg Sørensen16:00 Closing remarks16:10 End of day 2